Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 10:11 AM ET

Date/Time Source News Release
12/22/2022 07:53 AM EST GlobeNewswire Otonomy Announces Change in Stock Exchange Listing
12/19/2022 04:53 PM EST GlobeNewswire Otonomy Provides Corporate Update
11/10/2022 04:05 PM EST GlobeNewswire Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10/13/2022 07:30 AM EDT GlobeNewswire Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss
08/01/2022 07:30 AM EDT GlobeNewswire Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
07/25/2022 04:05 PM EDT GlobeNewswire Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
07/18/2022 07:30 AM EDT GlobeNewswire Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
05/18/2022 07:30 AM EDT GlobeNewswire Otonomy to Participate in the H.C. Wainwright Global Investment Conference
05/12/2022 07:30 AM EDT GlobeNewswire Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting
05/09/2022 04:04 PM EDT GlobeNewswire Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update
Page

Additional News

As of April 30, 2025 • 10:11 AM ET

Date/Time Source News Release
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.